X

Novel Drugs

Jubilant Pharmova Ltd Q4FY24; 5% rise in Revenue

Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services…

Jubilant Pharmova Ltd Q3FY24; 8% rise in Revenue

Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services…

Biocon Q2FY23 results out: Revenue up by 26%

Biocon Ltd reported a 49 percent slump in consolidated net profit at INR 82 crore for the quarter ended September…

Jubilant Pharmova reports dip in its net profit by 97% for Q2FY23

Jubilant Pharmova reported total income of INR 1,599.5 crores during the period ended September 30, 2022 as compared to INR…

Jubilant Pharmova reports dip in its net profit by 71% for Q1FY23

Jubilant Pharmova reported total income of INR 1,452 crores during the period ended June 30, 2022 as compared to INR…

Infographic: Biocon opens this year with a stellar performance reporting 71% growth in profits

Biocon on Wednesday reported 71% year-on-year (YoY) jump in net profit to Rs 144 crore during Q1FY23, driven by sales…